Company Presentations are an integral programming element at BIO Investor Forum Digital that allow companies to discuss their pipeline, R&D activities, and future fundraising goals to this exclusive audience of investors and collaboration partners.
Access 13-minute presentations by 150+ biotech companies poised to join the growth “watch list”, plus a number of nonprofit and venture philanthropy organizations.
Presenters tend to receive double the number of BIO One-on-One Partnering™ requests than non-presenters, and schedule twice as many meetings. Companies are also spotlighted in BIO’s marketing materials.
Companies and organizations present at the BIO Investor Forum to get in front of an exclusive audience of public and private equity investors, plus other biotech executives. (Since 2011, 44% of all US therapeutic IPO companies participated in a BIO Investor Forum event as a private company.)
Presenters are from early and established private companies, and emerging public companies. Companies must have a clear R&D focus, with a pipeline involving biotech therapeutics, diagnostics, or platform technologies, and can include patient advocacy groups.